Toyota|$17.53 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$23.33 (¥3,764)+1.16%▲ (in JPY terms)
SoftBank|$33.99 (¥5,484)-1.22%▼ (in JPY terms)
MUFG|$21.76 (¥3,510)-1.52%▼ (in JPY terms)
Keyence|$526.85 (¥85,000)-0.13%▼ (in JPY terms)
Nintendo|$51.23 (¥8,265)+2.76%▲ (in JPY terms)
NTT|$0.99 (¥160)+0.88%▲ (in JPY terms)
Takeda|$34.60 (¥5,582)+0.76%▲ (in JPY terms)
Tokyo Electron|$351.75 (¥56,750)+4.13%▲ (in JPY terms)
Recruit|$100.19 (¥16,165)+22.79%▲ (in JPY terms)
ITOCHU|$12.96 (¥2,091)+0.50%▲ (in JPY terms)
Honda|$10.49 (¥1,692)+0.53%▲ (in JPY terms)
Shin-Etsu|$38.96 (¥6,286)+2.78%▲ (in JPY terms)
Tokio Marine|$48.05 (¥7,752)-2.36%▼ (in JPY terms)
Fast Retailing|$487.92 (¥78,720)-0.74%▼ (in JPY terms)
Toyota|$17.53 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$23.33 (¥3,764)+1.16%▲ (in JPY terms)
SoftBank|$33.99 (¥5,484)-1.22%▼ (in JPY terms)
MUFG|$21.76 (¥3,510)-1.52%▼ (in JPY terms)
Keyence|$526.85 (¥85,000)-0.13%▼ (in JPY terms)
Nintendo|$51.23 (¥8,265)+2.76%▲ (in JPY terms)
NTT|$0.99 (¥160)+0.88%▲ (in JPY terms)
Takeda|$34.60 (¥5,582)+0.76%▲ (in JPY terms)
Tokyo Electron|$351.75 (¥56,750)+4.13%▲ (in JPY terms)
Recruit|$100.19 (¥16,165)+22.79%▲ (in JPY terms)
ITOCHU|$12.96 (¥2,091)+0.50%▲ (in JPY terms)
Honda|$10.49 (¥1,692)+0.53%▲ (in JPY terms)
Shin-Etsu|$38.96 (¥6,286)+2.78%▲ (in JPY terms)
Tokio Marine|$48.05 (¥7,752)-2.36%▼ (in JPY terms)
Fast Retailing|$487.92 (¥78,720)-0.74%▼ (in JPY terms)

TERUMO CORPORATION (4543)

TSE 4543 · Precision Instruments

TERUMO CORPORATION

テルモ株式会社
$15.96 (¥2,576)
+252.5 (+10.87%)in JPY terms
Delayed quote · Yahoo Finance
🏢 Industry: Precision Instruments
🌐 ISIN: JP3546800008
📊 TSE: 4543
Company Overview

Terumo is one of Japan's leading medical device manufacturers, producing a comprehensive range of products including catheters, blood transfusion systems, surgical devices, and diabetes care equipment. The company serves healthcare providers across hospitals, clinics, and home care settings, with operations spanning Asia, the Americas, and Europe.

For international investors, Terumo offers meaningful exposure to the growing global medical device industry, underpinned by aging demographics and increasing healthcare utilization across both developed and emerging markets. The company's cardiovascular and interventional systems businesses are particularly well positioned to benefit from rising demand for minimally invasive cardiac procedures, while its established global sales network provides a stable platform for continued international expansion.

Recent Press Releases
2026-08-082026-08-07 TERUMO CORPORATION “Notice Regarding Revision of Consolidated Earnings Forecast for the Full Fiscal Year Ending March 2027 (PDF 112.46 KB).”2026-08-052026-08-04 TERUMO CORPORATION “Notice Regarding Completion of Payment for the Disposition of Treasury Stock as Restricted Stock Compensation (PDF 79.54 KB).”2026-08-052026-08-04 TERUMO CORPORATION “Notice Regarding the Finalization of the Issuance Details of Stock Options (Share Subscription Rights) (PDF 81.13 KB).”2026-07-092026-07-08 TERUMO CORPORATION “Terumo's research project on minimally invasive treatment of chronic total occlusion of ischemic heart disease using DX (imaging equipment) and the introduction of a dual-sensor imaging system has been selected for the Ministry of Economy, Trade and Industry's FY2024 Supplementary Global South Future-Oriented Co-creation Project Subsidy (Small-Scale Demonstration/FS Project).”2026-07-022026-07-01 TERUMO CORPORATION “Regarding the voluntary recall of certain varieties of the "RelayPro" thoracic stent graft system in overseas markets.”2026-06-302026-06-29 TERUMO CORPORATION “Terumo joins the "Tokyo Women Leaders Support Network" promoted by the Tokyo Metropolitan Government, aiming to promote sustainable growth by creating an environment where diverse talents can demonstrate their abilities.”2026-06-122026-06-11 TERUMO CORPORATION “Terumo, selected for the Ministry of Health, Labour and Welfare's "FY2026 International Promotion Project for Medical Technology," will enhance and expand its catheter treatment personnel training model, developed in Kenya, to East Africa.”2026-06-022026-06-01 TERUMO CORPORATION “Voluntary recall of certain varieties of the "RelayPro" thoracic stent graft system (PDF 696.12 KB).”2026-05-212026-05-20 TERUMO CORPORATION “Terumo Group's Vasquetech has received the King's Award (Corporate Category) in recognition of its custom-made approach to hybrid products.”2026-05-192026-05-18 TERUMO CORPORATION “Terumo's blood glucose management app, "Medisafe DataShare," has begun app integration with "Oishii Kenko" (Delicious Health). By combining blood glucose measurement and recording with meal selection suggestions, it will further support the lives of people with diabetes.”
Key Data
52W High
$17.47 (¥2,818)
52W Low
$11.78 (¥1,900)
TSE Code
4543
ISIN
JP3546800008